Skip to content

Aurinia Pharmaceuticals

US · AUPH #2749 by market cap Listed 1970
14.70 -0.19 -1.28%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
67.14% -0.46pp
Institutions
341 -2
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund44.56%
Hedge Fund8.99%
VC/PE Fund6.68%
Public Company4.38%
Individual/Insider2.17%
Government Pension Fund0.79%
Private Company0.73%
Insurance Company0.58%
Family Office/Trust0.17%
Bank/Investment Bank0.16%
Other30.96%

Top holders as of 2026-06-30

Tang Capital Management, LLC 9.73% · 13.04M sh
BlackRock 6.41% · 8.59M sh
ILJIN SNT Co., Ltd 3.72% · 4.99M sh
Goldman Sachs Asset Management, L.P. 3.65% · 4.88M sh
New Enterprise Associates, Inc. 2.96% · 3.97M sh
Two Sigma Investments, LP 2.59% · 3.47M sh
Arrowstreet Capital, Limited Partnership 2.44% · 3.26M sh
State Street Global Advisors 1.93% · 2.59M sh
Morgan Stanley 1.55% · 2.06M sh
Marshall Wace LLP 1.53% · 2.04M sh
LSV Asset Management 1.35% · 1.81M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 27 buys · 23 sells

NameRoleStake
Peter Greenleaf Consultant 0.78%
Matthew Donley Former Chief Operating Officer 0.33%
Joseph Miller Former Chief Financial Officer 0.26%
Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer 0.23%
David R. Jayne Former Director 0.03%
Gregory Keenan Former Chief Medical Officer 0.02%
Jeffrey Bailey Independent Director 0.02%
Craig Johnson Lead Independent Director 0.01%
Jill Leversage Former Director 0.01%
Karen Smith Former Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-09 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Open Market Disposition -11,939 $15.95
2026-08-20 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Open Market Disposition -20,975 $16.97
2026-06-04 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -9,593 $16.52
2026-06-03 Tina Nova Independent Director Other Derivative Acquisition +23,931 $15.67
2026-06-03 Craig Johnson Lead Independent Director Other Derivative Acquisition +23,931 $15.67
2026-06-03 Jeffrey Bailey Independent Director Other Derivative Acquisition +23,931 $15.67
2026-06-03 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -25,000 $16.34
2026-06-03 Kathleen Goetz -- Other Derivative Acquisition +23,931 $15.67
2026-06-01 Tang Capital Management, LLC -- Open Market Acquisition +814,606 $15.28–15.35
2026-06-01 Tang Capital Management, LLC -- Other Derivative Acquisition +10,000 $15.00
2026-06-01 Gregory Keenan Former Chief Medical Officer Intent to Sell (Form 144) -25,000 $2,164.00
2026-05-17 Michael Hearne Chief Financial Officer Other Acquisition +116,144 --
2026-05-17 Michael Hearne Chief Financial Officer Other Derivative Acquisition +70,230 $15.28
2026-05-17 Ryan Cole Chief Operating Officer Other Acquisition +116,144 --
2026-05-17 Ryan Cole Chief Operating Officer Other Derivative Acquisition +70,230 $15.28
2026-05-17 Stephen Robertson Chief Legal Officer, Corporate Secretary & Chief Compliance Officer Other Acquisition +115,541 --
2026-05-10 Peter Greenleaf Consultant Intent to Sell (Form 144) -3,136,201 $15.84
2026-05-10 Joseph Miller Former Chief Financial Officer Intent to Sell (Form 144) -500,503 $15.84
2026-03-05 Gregory Keenan Former Chief Medical Officer Sale to Issuer -8,069 $14.32
2026-03-02 Tang Capital Management, LLC -- Open Market Acquisition +898,400 $13.90–14.33

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:19 · For reference only, not investment advice and not tailored to your situation.

Aurinia Pharmaceuticals discussion 0 comments

Add a comment